The impact of smoking on the effectiveness of immune checkpoint inhibitors ??a systematic review and meta-analysis
Journal
Acta Oncologica
Journal Volume
59
Journal Issue
1
Pages
96-100
Date Issued
2020
Author(s)
SDGs
Other Subjects
anaplastic lymphoma kinase; antineoplastic monoclonal antibody; epidermal growth factor receptor; immunological antineoplastic agent; cancer chemotherapy; cancer immunotherapy; disease burden; drug efficacy; ex-smoker; human; Letter; never smoker; overall survival; priority journal; smoking; systematic review; systemic therapy; adverse event; aged; head and neck tumor; immunotherapy; lung tumor; meta analysis; middle aged; non small cell lung cancer; procedures; randomized controlled trial (topic); smoking; treatment outcome; Aged; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Humans; Immunotherapy; Lung Neoplasms; Middle Aged; Randomized Controlled Trials as Topic; Smoking; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome
Publisher
Taylor and Francis Ltd
Type
letter